Indaptus Therapeutics (INDP) Income Statement (2020 - 2026)
Income Statement report data from Mar 31, 2020 to Mar 31, 2026 for Indaptus Therapeutics (INDP).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Expenses | |||||||||||||||||||||||||
Research And Development | 490K (-82.81%) | 2.85M (+87.50%) | 1.52M (-29.95%) | 2.17M (-22.78%) | 2.81M (+13.31%) | 2.48M (+68.71%) | 1.47M (-14.04%) | 1.71M (+7.55%) | 1.59M (-21.67%) | 2.03M (-8.97%) | 2.23M (+50.68%) | 1.48M (-21.28%) | 1.88M (-1.57%) | 1.91M (+18.63%) | 1.61M (+6.62%) | 1.51M (+16.15%) | 1.30M (+38.30%) | 940K (+34.29%) | 700K (+79.49%) | 390K (-20.41%) | 490K (+1533.33%) | 30K (-97.78%) | 1.35M (+6.30%) | 1.27M | - |
Selling General And Administrative | 1.67M (-68.55%) | 5.31M (+369.91%) | 1.13M (-50.66%) | 2.29M (+30.11%) | 1.76M (+4.14%) | 1.69M (+0.60%) | 1.68M (-29.71%) | 2.39M (+1.70%) | 2.35M (+9.30%) | 2.15M (+6.44%) | 2.02M (+0.50%) | 2.01M (-22.09%) | 2.58M (+18.35%) | 2.18M (+12.37%) | 1.94M (-17.80%) | 2.36M (+12.38%) | 2.10M (-7.49%) | 2.27M (-14.98%) | 2.67M (+1807.14%) | 140K (+16.67%) | 120K | -880.00K | 200K (-87.73%) | 1.63M | - |
Operating Expenses | 2.16M (-73.53%) | 8.16M (+207.92%) | 2.65M (-40.58%) | 4.46M (-2.41%) | 4.57M (+9.59%) | 4.17M (+32.80%) | 3.14M (-23.60%) | 4.11M (+4.31%) | 3.94M (-5.74%) | 4.18M (-1.65%) | 4.25M (+21.43%) | 3.50M (-21.52%) | 4.46M (+9.05%) | 4.09M (+15.21%) | 3.55M (-8.27%) | 3.87M (+13.82%) | 3.40M (+5.59%) | 3.22M (-4.45%) | 3.37M (+535.85%) | 530K (-13.11%) | 610K | -850.00K | 1.55M (-46.74%) | 2.91M | - |
Operating Income | |||||||||||||||||||||||||
Operating Income | -2.16M (-73.53%) | -8.16M (+207.92%) | -2.65M (-40.58%) | -4.46M (-2.41%) | -4.57M (+9.59%) | -4.17M (+32.80%) | -3.14M (-23.60%) | -4.11M (+4.31%) | -3.94M (-5.74%) | -4.18M (-1.65%) | -4.25M (+21.43%) | -3.50M (-21.52%) | -4.46M (+9.05%) | -4.09M (+15.21%) | -3.55M (-8.27%) | -3.87M (+13.82%) | -3.40M (+5.59%) | -3.22M (-4.45%) | -3.37M (+535.85%) | -530.00K (-13.11%) | -610.00K | 850K | -1.55M (-46.55%) | -2.90M | - |
Ebit | -2.16M (-73.53%) | -8.16M (+207.92%) | -2.65M (-40.58%) | -4.46M (-2.41%) | -4.57M (+9.59%) | -4.17M (+32.80%) | -3.14M (-23.60%) | -4.11M (+4.31%) | -3.94M (-5.74%) | -4.18M (-1.65%) | -4.25M (+21.43%) | -3.50M (-21.52%) | -4.46M (+9.05%) | -4.09M (+15.21%) | -3.55M (-8.27%) | -3.87M (+13.82%) | -3.40M (+5.59%) | -3.22M (-4.45%) | -3.37M (+535.85%) | -530.00K (-13.11%) | -610.00K | 1.41M | -1.55M (-46.55%) | -2.90M (+417.86%) | -560.00K |
EBITDA | -2.54M (-68.68%) | -8.11M (+172.15%) | -2.98M (-43.02%) | -5.23M (+15.45%) | -4.53M (+4.38%) | -4.34M (+41.37%) | -3.07M (-23.63%) | -4.02M (+2.03%) | -3.94M (-17.05%) | -4.75M (+21.17%) | -3.92M (+20.62%) | -3.25M (-26.97%) | -4.45M (+5.70%) | -4.21M (+21.33%) | -3.47M (-9.64%) | -3.84M (+12.94%) | -3.40M (+4.94%) | -3.24M (-3.86%) | -3.37M (+574.00%) | -500.00K (-18.03%) | -610.00K (-26.51%) | -830.00K (-46.10%) | -1.54M (+129.85%) | -670.00K (+19.64%) | -560.00K |
Other Income / Expenses | |||||||||||||||||||||||||
Other Non Operating Income | -380.00K | - | - | - | 40K (-88.24%) | 340K (+385.71%) | 70K (-22.22%) | 90K (-35.71%) | 140K (-85.42%) | 960K (+190.91%) | 330K (+32.00%) | 250K (+25.00%) | 200K (-66.10%) | 590K (+555.56%) | 90K (+200.00%) | 30K (-25.00%) | 40K (+100.00%) | 20K | - | 10K | - | 20K | - | - | - |
Net Income | |||||||||||||||||||||||||
Income Before Tax | - | -20.85M | - | - | - | -15.02M | - | - | - | - | - | - | - | - | - | - | - | 7.42M | - | -7.42M | - | 2.90M | - | -2.90M | - |
Income Tax Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -10.00K | - | 10K | - | -50.00K | - | 50K | - |
Net Income From Continuing Operations | -2.54M (-68.68%) | -8.11M (+172.15%) | -2.98M (-43.02%) | -5.23M (+15.45%) | -4.53M (+9.69%) | -4.13M (+34.53%) | -3.07M (-23.63%) | -4.02M (+5.51%) | -3.81M (-4.75%) | -4.00M (+2.04%) | -3.92M (+20.62%) | -3.25M (-23.53%) | -4.25M (+16.12%) | -3.66M (+5.48%) | -3.47M (-9.64%) | -3.84M (+13.95%) | -3.37M (+4.66%) | -3.22M (-4.45%) | -3.37M (+548.08%) | -520.00K (-14.75%) | -610.00K (-20.78%) | -770.00K (-50.00%) | -1.54M (+116.90%) | -710.00K (+26.79%) | -560.00K |
Net Income | -2.54M (-68.68%) | -8.11M (+172.15%) | -2.98M (-43.02%) | -5.23M (+15.45%) | -4.53M (+9.69%) | -4.13M (+34.53%) | -3.07M (-23.63%) | -4.02M (+5.51%) | -3.81M (-4.75%) | -4.00M (+2.04%) | -3.92M (+20.62%) | -3.25M (-23.53%) | -4.25M (+16.12%) | -3.66M (+5.48%) | -3.47M (-9.64%) | -3.84M (+13.95%) | -3.37M (+4.66%) | -3.22M (-4.45%) | -3.37M (+548.08%) | -520.00K (-14.75%) | -610.00K (-20.78%) | -770.00K (-50.00%) | -1.54M (+116.90%) | -710.00K (+26.79%) | -560.00K |
Comprehensive Income Net Of Tax | - | - | - | - | - | -15.02M (+389.25%) | -3.07M (-23.63%) | -4.02M (+5.51%) | -3.81M (-75.45%) | -15.52M (+282.27%) | -4.06M (+23.40%) | -3.29M (-21.10%) | -4.17M (-70.70%) | -14.23M (+316.08%) | -3.42M (-11.17%) | -3.85M (+14.24%) | -3.37M (-56.29%) | -7.71M (+128.78%) | -3.37M (+548.08%) | -520.00K (-14.75%) | -610.00K | - | - | - | - |